Journals / Journal of Clinical and Experimental Investigations / 2013 / Cilt: 4 - Sayı: 4

Assessment of mean platelet volume in chronic obstructive pulmonary disease during stable period and acute exacerbation

Kronik obstrüktif akciğer hastalığının akut alevlenme ve stabil dönemlerinde ortalama trombosit hacminin incelenmesi

Pages
483–487
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Mean platelet volume (MPV) is one of the markers indicating platelet activation, and it was found to be high in many diseases related to inflammation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Chronic obstructive pulmonary disease (COPD) is an important public health problem and it is associated with systemic inflammation.
📊
Key Findings & Data:Methods: In this retrospective study, data of 40 patients with acute exacerbation of COPD, 43 stable COPD pa- tients and 40 healthy subjects were evaluated.
💡
Conclusion & Impact:Mean platelet volume (MPV) is one of the markers indicating platelet activation, and it was found to be high in many diseases related to inflammation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Chronic obstructive pulmonary disease (COPD) is an important public health problem and it is associated with systemic inflammation. Mean platelet volume (MPV) is one of the markers indicating platelet activation, and it was found to be high in many diseases related to inflammation. In previous studies reported dif- ferent results evaluating of MPV in COPD. In this study, we aimed to evaluate of C-reactive protein (CRP), white blood cell (WBC), and MPV in acute exacerbation of COPD and stable COPD patients. Methods: In this retrospective study, data of 40 patients with acute exacerbation of COPD, 43 stable COPD pa- tients and 40 healthy subjects were evaluated. Results: The mean MPV, CRP and WBC were found in control, stable COPD and acute exacerbation of COPD groups, 7.9±1.1; 8.2±1.3 and 8.7±1.6 fL; 3.4±1.2; 5.2±3.5 and 27.5±23.6 mg/L; 7.8±1.6; 8.1±2.1 and 11.4±4.5 x103/ ϻL, respectively. The mean WBC and CRP in the acute exacerbation of COPD group were significantly higher than the other groups (for both values p ˂0.001). The mean MPV in the acute exacerbation of COPD group was found higher than in the other groups. The mean MPV values were significantly higher in patients of acute exac- erbation than control subjects (p=0.030). Conclusion: The results of this study suggest that the increased MPV may be a marker for the evaluation acute exacerbation of COPD as well as the classic acute phase reactant CRP.

Özet

Amaç: Kronik Obstrüktif Akciğer Hastalığı (KOAH) önemli bir halk sağlığı sorunudur ve sistemik inflamasyonla ilişkilidir. Ortalama trombosit hacmi (OTH) trombosit aktivasyonunu gösteren belirteçlerden biridir ve inflamasyonla ilişkili birçok hastalıkta yüksek bulunmuştur. KOAH’daOTH’nin değerlendirildiği çalışmalarda farklı sonuçlar bildirilmiştir. Bu çalışmada KOAH akut alevlenme ve stabil KOAH hastalarında C-reaktif protein (CRP), beyaz küre(BK) ve OTH’nin değerlendirilmesi amaçlanmıştır.Yöntemler: Bu çalışmada cinsiyet ve yaş bakımından benzer 40 KOAH akut alevlenme ve 43 stabil KOAH hastası ile 40 sağlıklı bireyin verileri retrospektif olarak değerlendirildi. Bulgular: Kontrol, stabil KOAH ve KOAH akut alevlenme gruplarında ortalama OTH, CRP ve BK sırasıyla; 7,9±1,1; 8,2±1,3 ve 8,7±1,6 fL; 3,4±1,2; 5,2±3,5 ve 27,5±23,6 mg/L; 7,8±1,6; 8,1±2,1 ve 11,4±4,5 x103/ ϻL olarak bulundu. Ortalama BK ve CRP, KOAH akut alevlenme grubunda diğer iki gruba göre anlamlı yüksek bulundu (Her iki değer için p ˂0,001). Ortalama OTH, KOAH akut alevlenme grubunda diğer gruplara göre yüksek bulundu ve akut alevlenme hastalarındaki bu yüksek değer kontrol grubuna göre istatistiksel olarak anlamlıydı (p=0,030). Sonuç: Bu çalışmanın sonuçları klasik akut faz reaktanı olan CRP gibi yüksek OTH’ninde KOAH akut alevlenmenin değerlendirilmesinde kullanılabilecek bir belirteç ola- bileceğini düşündürmektedir.

🔖

Cite This Article

YENGİL, E., ERDEN, E. Ş., MOTOR, S., DOĞRU, S., DOKUYUCU, R., DEMİRKÖSE, M., KAYIM, H. B., SEFİL, F. (2022). Assessment of mean platelet volume in chronic obstructive pulmonary disease during stable period and acute exacerbation. Journal of Clinical and Experimental Investigations, Cilt: 4 - Sayı: 4, 483–487. https://ajindex.com/articles/561787

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chron- ic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347- 365
  2. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33:1165- 1185
  3. Gan WQ, Man SF, Senthilselvan A, Sin DD. Associa- tion between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59:574-580
  4. Thomsen M, Ingebrigtsen TS, Marott JL, et al. Inflam- matory biomarkers and exacerbations in chronic ob- structive pulmonary disease. JAMA 2013;309:2353- 2361
  5. Agusti A, Edwards LD, Rennard SI, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 2012;7:37483
  6. Saldias PF, Diaz PO, Dreyse DJ,et al. Etiology and bio- markers of systemic inflammation in mild to moderate COPD exacerbations. Rev Med Chil 2012;140:10-18
  7. Smyth SS, McEver RP, Weyrich AS, et al. Platelet functions beyond hemostasis. J Thromb Haemost 2009;7:1759-1766
  8. Briggs C. Quality counts: new parameters in blood cell counting. Int J Lab Hematol 2009;31:277-297. 9. van der Loo B, Martin JF. Megakaryocytes and plate- lets in vascular disease. Baillieres Clin Haematol 1997;10:109-123
  9. Kanbay A, Tutar N, Kaya E, et al. Mean platelet vol- ume in patients with obstructive sleep apnea syndrome and its relationship with cardiovascular diseases. Blood Coagul Fibrinolysis 2013;24:532-536
  10. Arica S, Ozer C, Arica V, et al. Evaluation of the mean platelet volume in children with familial Mediterranean fever. Rheumatol Int 2012;32:3559-3563
  11. Albayrak Y, Albayrak A, Albayrak F, et al. Mean platelet volume: a new predictor in confirming acute appendicitis diagnosis. Clin Appl Thromb Hemost 2011;17:362-366
  12. Ayhan Tuzcu E, Arica S, Ilhan N, et al. Relationship between mean platelet volume and retinopathy in patients with type 2 diabetes mellitus. Graefes Arch Clin Exp Ophthalmol 2013 Aug 17 (Epub ahead of print)
  13. Akgul O, Uyarel H, Pusuroglu H, et al. Prognostic value of elevated mean platelet volume in patients undergoing primary angioplasty for ST-elevation myocardial infarction. Acta Cardiol 2013;68:307-314
  14. Yılmaz N, Özkan OV, Büyükbaş S, et al. Mean platelet volume in patients with acute pancreatitis. J Clin Exp Invest 2011;2:362-365
  15. Steiropoulos P, Papanas N, Nena E, et al. Mean platelet